Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
K36 Therapeutics, Inc.
Blue Earth Therapeutics Ltd
Washington University School of Medicine
Spanish Oncology Genito-Urinary Group
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
RenJi Hospital
The Netherlands Cancer Institute
Jinling Hospital, China
Pathos AI, Inc.
Johns Hopkins University
Ottawa Hospital Research Institute
Marengo Therapeutics, Inc.
Endocyte
Stanford University
UroGen Pharma Ltd.
Algemeen Ziekenhuis Maria Middelares
Regina Elena Cancer Institute
VA Greater Los Angeles Healthcare System